Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (391-400 of 632) with videos related to

Pageof 64
Sort By:
International Journal of Cancer|April 19, 2011
The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis CHans-Dieter Nischalke, Martin Coenen, Cordula Berger, et al.
Deutsches Arzteblatt International|February 7, 2022
Declining Numbers of Hepatitis C Virus-Associated Liver Transplantations in GermanyHeiner Wedemeyer, Kerstin Herzer, Yvonne Serfert, et al.
The Lancet. Haematology|April 30, 2025
Updated recommendations for the management of hepatitis B, C, and E virus infections in patients with haematological malignancies and those undergoing haematopoietic cell transplantation: recommendations from the 9th European Conference on Infections in Leukaemia (ECIL-9)Malgorzata Mikulska, Florian van Bömmel, Charlotte Mouliade, et al.
Hepatology (Baltimore, Md.)|March 8, 2018
Host and viral factors associated with serum hepatitis B virus RNA levels among patients in need for treatmentMargo J H van Campenhout, Florian van Bömmel, Maria Pfefferkorn, et al.
Hepatology (Baltimore, Md.)|December 24, 2008
The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BBHermann E Wasmuth, Carmen G Tag, Eddie Van de Leur, et al.
Plos One|November 9, 2013
Association of IFNL3 rs12979860 and rs8099917 with biochemical predictors of interferon responsiveness in chronic hepatitis C virus infectionJanett Fischer, Stephan Böhm, Tobias Müller, et al.
Journal of Hepatology|December 17, 2011
The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patientsHans Dieter Nischalke, Cordula Berger, Carolin Luda, et al.
Hepatology Communications|April 14, 2022
Body fat composition determines outcomes before and after liver transplantation in patients with cirrhosisCornelius Engelmann, Niklas F Aehling, Stefan Schob, et al.
Hepatology (Baltimore, Md.)|August 3, 2007
Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effectsMartin Schaefer, Axel Hinzpeter, Ariane Mohmand, et al.
Plos One|May 10, 2021
Barriers to initiation of hepatitis C virus therapy in Germany: A retrospective, case-controlled studyPeter Buggisch, Hans Heiken, Stefan Mauss, et al.
Pageof 64

Showing results (391-400 of 632) with videos related to

Sort By:
Pageof 64
International Journal of Cancer|April 19, 2011
The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis CHans-Dieter Nischalke, Martin Coenen, Cordula Berger, et al.
Deutsches Arzteblatt International|February 7, 2022
Declining Numbers of Hepatitis C Virus-Associated Liver Transplantations in GermanyHeiner Wedemeyer, Kerstin Herzer, Yvonne Serfert, et al.
The Lancet. Haematology|April 30, 2025
Updated recommendations for the management of hepatitis B, C, and E virus infections in patients with haematological malignancies and those undergoing haematopoietic cell transplantation: recommendations from the 9th European Conference on Infections in Leukaemia (ECIL-9)Malgorzata Mikulska, Florian van Bömmel, Charlotte Mouliade, et al.
Hepatology (Baltimore, Md.)|March 8, 2018
Host and viral factors associated with serum hepatitis B virus RNA levels among patients in need for treatmentMargo J H van Campenhout, Florian van Bömmel, Maria Pfefferkorn, et al.
Hepatology (Baltimore, Md.)|December 24, 2008
The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BBHermann E Wasmuth, Carmen G Tag, Eddie Van de Leur, et al.
Plos One|November 9, 2013
Association of IFNL3 rs12979860 and rs8099917 with biochemical predictors of interferon responsiveness in chronic hepatitis C virus infectionJanett Fischer, Stephan Böhm, Tobias Müller, et al.
Journal of Hepatology|December 17, 2011
The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patientsHans Dieter Nischalke, Cordula Berger, Carolin Luda, et al.
Hepatology Communications|April 14, 2022
Body fat composition determines outcomes before and after liver transplantation in patients with cirrhosisCornelius Engelmann, Niklas F Aehling, Stefan Schob, et al.
Hepatology (Baltimore, Md.)|August 3, 2007
Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effectsMartin Schaefer, Axel Hinzpeter, Ariane Mohmand, et al.
Plos One|May 10, 2021
Barriers to initiation of hepatitis C virus therapy in Germany: A retrospective, case-controlled studyPeter Buggisch, Hans Heiken, Stefan Mauss, et al.
Pageof 64